June 22, 2020 / 1:15 PM / 2 months ago

BRIEF-New Preclinical Data On Alks 4230 In Combination With Lucitanib To Be Presented At 2020 AACR Meeting

June 22 (Reuters) - Alkermes Plc:

* NEW PRECLINICAL DATA ON ALKS 4230 IN COMBINATION WITH LUCITANIB TO BE PRESENTED AT 2020 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) VIRTUAL ANNUAL MEETING II Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below